Showing results (351-360 of 394) with videos related to

Sort By:
Pageof 40
Allergy|March 26, 2018
Childhood asthma clusters reveal neutrophil-predominant phenotype with distinct gene expressionM-W Su, W-C Lin, C-H Tsai, et al.
The Journal of Investigative Dermatology|April 20, 2000
Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regenerationL C Wang, Z Y Liu, L Gambardella, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 23, 1998
Neurturin exerts potent actions on survival and function of midbrain dopaminergic neuronsB A Horger, M C Nishimura, M P Armanini, et al.
JCO Oncology Practice|January 13, 2021
Early Outcomes of a National Cancer Center's Strategy Against COVID-19 Executed Through a Disease Outbreak Response TaskforceJin Wei Kwek, Jack J Chan, Ravindran Kanesvaran, et al.
Asia-Pacific Journal of Clinical Oncology|December 15, 2021
Efficacy, toxicity, and quality-of-life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single-arm phase 2 trial from AsiaJanice S H Tan, Jonathan Y H Teh, Laura L Y Tan, et al.
Cancer Biology & Medicine|May 24, 2019
68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomyJanice S H Tan, Charles X Y Goh, Yen Sin Koh, et al.
Technical Innovations & Patient Support in Radiation Oncology|May 19, 2021
The implementation of an advanced practice radiation therapy (APRT) program in SingaporeSharon M M Wong, S Y Sin, L H Lim, et al.
Neuron|March 10, 1998
Persephin, a novel neurotrophic factor related to GDNF and neurturinJ Milbrandt, F J de Sauvage, T J Fahrner, et al.
Liver Cancer|July 8, 2016
National Cancer Centre Singapore Consensus Guidelines for Hepatocellular CarcinomaPierce K H Chow, Su Pin Choo, David C E Ng, et al.
Zhonghua Yi Xue Za Zhi|November 14, 2023
[Effect of recombinant human thrombin for hemostasis in liver resection: a randomized controlled phase Ⅲ clinical trial]S Yan, C Y Tu, C Y Du, et al.
Pageof 40